Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
Sales | 417,920 | 642,570 | 806,500 | 721,651 | 775,759 |
Cost of Goods | 632,000 | N/A | N/A | N/A | N/A |
Gross Profit | 1,975,000 | 642,570 | 806,500 | 721,651 | 775,759 |
Operating Expenses | 1,444,000 | 0 | 0 | 0 | 0 |
Operating Income | -1,658,080 | 642,570 | 806,500 | 721,651 | 775,759 |
Interest Expense | 45,000 | 0 | 0 | 0 | 0 |
Other Income | 1,839,230 | -501,910 | -621,880 | -577,081 | 0 |
Pre-tax Income | 136,150 | 140,660 | 184,620 | 144,570 | 775,759 |
Income Tax | 43,860 | 53,310 | 68,500 | 53,330 | N/A |
Net Income Continuous | 92,300 | 87,350 | 116,120 | 88,974 | 92,852 |
Net Income | $92,300 | $87,350 | $116,120 | $88,974 | $92,852 |
EPS Basic Total Ops | N/A | N/A | N/A | 0.01 | 0.01 |
EPS Basic Continuous Ops | N/A | N/A | N/A | 0.01 | 0.01 |
EPS Diluted Total Ops | N/A | N/A | N/A | 0.01 | 0.01 |
EPS Diluted Continuous Ops | N/A | N/A | N/A | 0.01 | 0.01 |
EBITDA(a) | $-1,658,080 | $642,570 | $806,500 | $721,651 | $775,759 |